Dupilumab found to lessen disease in COPD patients with type 2 inflammation
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab, according to a yearlong, Phase 3 clinical ...
Jun 20, 2023
0
9